Please provide your email address to receive an email when new articles are posted on . A trial that evaluated three alternative treatments for anogenital gonorrhea found that a single dose of ...
Amid growing concern about antimicrobial resistance, researchers have identified a potential alternative to current first-line antibiotic therapy for genital gonorrhea. Results from G-ToG, the first ...
Please provide your email address to receive an email when new articles are posted on . Gonorrhea is the second most common STI, with more than 82 million new infections globally each year, including ...
Zoliflodacin noninferior to ceftriaxone plus azithromycin, with similar safety profile. (HealthDay News) — Zoliflodacin is noninferior to ceftriaxone plus azithromycin for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results